免疫性血小板缺血:万科米辛治疗的罕见不良事件
Emeka S Obi1, Devdat Lnu2,3, Norense O Ehimwenma4
1Department of Health Administration, College of Public Health, East Tennessee State University, Johnson City, USA.
Cureus
|June 23, 2023
概括
范科米辛是一种治疗严重感染的抗生素,很少会导致免疫性血小板缺血,即血小板数量下降. 这一案例凸显了在科米辛治疗期间监测血小板水平的重要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
背景情况:
- 范科米辛是一种关键的糖抗生素,用于严重的格拉姆阳性细菌感染.
- 虽然不常见,但随着万科米辛治疗可能会发生不良反应.
- 免疫性血小板缺血是一种罕见但严重的潜在副作用.
研究的目的:
- 报告一种范科米辛诱导的免疫血小板缩病例 (VIIT).
- 强调VIIT的诊断挑战和临床表现.
- 强调在万科米辛治疗期间考虑在患有血小板狭窄症的患者中进行VIIT的重要性.
主要方法:
- 一个56岁的男性糖尿病足感染的案例研究.
- 在开始使用万科米辛后,对血小板数的监测.
- 实验室测试康素诱导的抗血小板抗体.
- 排除了血小板缺血的其他原因.
主要成果:
- 患者在开始范科米辛治疗后出现严重的血小板缺血症.
- 在停用万科米辛后血小板数正常化.
- 阳性范科米辛诱导的抗血小板抗体证实了诊断.
- 系统地排除了血小板缺血的其他原因.
结论:
- 范科米辛可以诱导免疫血小板缺血,这是一个严重的药物不良反应.
- 迅速识别和停止使用万科米对于康复至关重要.
- 诊断确认包括抗体检测和排除其他病因.
相关概念视频
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Venous Thrombosis IV: Nursing Management
15
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
15
Endocarditis IV: Nursing Management
16
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
16
Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8


